Kornowski R, Meltzer R S, Chernine A, Vered Z, Battler A
Neufeld Cardiac Research Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Circulation. 1994 Jan;89(1):339-44. doi: 10.1161/01.cir.89.1.339.
Prior in vitro and in vivo studies have reported that external ultrasound accelerates thrombolysis at intensities too low to have a direct effect on clot dissolution in the absence of a thrombolytic agent. The present study was undertaken to examine the ultrasound effect on thrombolysis and reocclusion in a rabbit thrombosis model.
Blood clots were produced in a femoral artery segment with endothelial damage and distal stenosis. Recombinant tissue-type plasminogen activator (rTPA) was infused at 30 micrograms.kg-1.min-1 for 60 minutes. Femoral artery flow was measured every 5 minutes for 2 hours. Rabbits were randomized to four groups with continuous wave ultrasound on or off with or without intravenous injection of 17 mg/kg aspirin (+US/-US/+Asp/-Asp). Ultrasound frequency and intensity were 1 MHz and 6.3 W/cm2. In seven of eight and five of five rabbits given rTPA and -US/-Asp or -US/+Asp, respectively, reflow was observed, persisting to the end of the observation period. In five of nine and four of five rabbits given rTPA and +US/-Asp or +US/+Asp, reflow was achieved, but persistent reocclusion was subsequently observed in five of five and two of four of these rabbits, respectively. Overall, femoral artery patency was worse and reocclusion occurred more often when ultrasound was added to rTPA (P = .002 by nonparametric ANOVA). However, initial reflow occurred more rapidly with ultrasound exposure (21 +/- 10 and 33 +/- 6 minutes for the +US/+Asp and +US/-Asp groups, respectively) compared with without ultrasound (46 +/- 13 and 74 +/- 14 minutes for the -US/+Asp and -US/-Asp groups, respectively) (P = .03 by ANOVA).
Although time to initial reflow was shortened by ultrasound, it was associated with less reperfusion and more reocclusion in this model. A possible explanation for these results is ultrasound-induced platelet activation counterbalancing its thrombolysis-accelerating effect.
先前的体外和体内研究报道,在没有溶栓剂的情况下,外部超声以过低的强度加速血栓溶解,而这种强度对血凝块溶解没有直接影响。本研究旨在检查超声对兔血栓形成模型中血栓溶解和再闭塞的影响。
在股动脉段造成内皮损伤和远端狭窄以形成血凝块。以30微克·千克⁻¹·分钟⁻¹的速度注入重组组织型纤溶酶原激活剂(rTPA),持续60分钟。在2小时内每5分钟测量一次股动脉血流。将兔子随机分为四组,分别接受连续波超声照射(开或关)以及静脉注射17毫克/千克阿司匹林(+US/-US/+Asp/-Asp)。超声频率和强度分别为1兆赫和6.3瓦/平方厘米。在分别接受rTPA且-US/-Asp或-US/+Asp的八只兔子中的七只和五只兔子中,观察到血流恢复,并持续到观察期结束。在分别接受rTPA且+US/-Asp或+US/+Asp的九只兔子中的五只和五只兔子中的四只中,实现了血流恢复,但随后在这些兔子中的五只和四只中的两只中分别观察到持续性再闭塞。总体而言,当超声与rTPA联合使用时,股动脉通畅性更差,再闭塞更频繁发生(非参数方差分析,P = 0.002)。然而,与未接受超声照射相比(-US/+Asp和-US/-Asp组分别为46±13分钟和74±14分钟),接受超声照射时初始血流恢复更快(+US/+Asp和+US/-Asp组分别为21±10分钟和33±6分钟)(方差分析,P = 0.03)。
尽管超声缩短了初始血流恢复时间,但在该模型中它与再灌注减少和再闭塞增加有关。这些结果的一个可能解释是超声诱导的血小板活化抵消了其加速血栓溶解的作用。